A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, radiation and chemotherapy.

However, the new immuno-based treatment would only require a single step — immunotherapy — to treat the cancer by teaching a person’s immune system to recognize and attack cancer cells.

Hodgkin's lymphoma and acute lymphoblastic leukemia—two types of cancer that affect blood cells—do not respond adequately to treatment with CAR-T cells. The therapy involves harvesting the patient's ...

New cancer research pioneered ... particularly vulnerable to a type of immunotherapy called "checkpoint inhibitors." This therapy "unmasks" tumor cells, MSK stated, making it easier for the ...

Adoptive Cell Transfer (ACT) includes a class of immunotherapy approaches to treat cancer. This procedure focuses on a special type of immune cell called T cells. These cells, particularly the subset ...

A pair of recent studies from the laboratory of Bin Zhang, MD, Ph.D., the Johanna Dobe Professor of Cancer Immunology, have ...

Researchers from MIT and Dana-Farber Cancer ... Immunotherapy treatments such as checkpoint blockade inhibitors, which are designed to help stimulate the body's own T cells to attack tumor cells ...

Immunotherapy drugs work by teaching a person’s immune system to recognize and attack cancer cells. The drugs have been found to work particularly well against tumors with mismatch repair ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from ...

No other drugs, except for the immunotherapy treatment, dostarlimab, were given. Basically, it allows the immune system to recognize cancer cells and attack them, NBC News reported. Forty-nine ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T ...